Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Factor Xa Inhibitory Profile of Apixaban, Betrixaban, Edoxaban and Rivaroxaban Does Not Fully Reflect Their Biologic Spectrum

Fakiha Siddiqui, Siddharth Mehrotra, Vishnu Venkitasubramony, Rithik Raina, Lorenzo Storino Ramacciotti, Jack Bontekoe, BS, Omer Iqbal, MD, Debra Hoppensteadt, PhD, Walter Jeske, PhD, Jawed Fareed, PhD

Blood (2018) 132 (Supplement 1): 2520.

https://doi.org/10.1182/blood-2018-99-116993

Published: 2018

Journal Articles

MG1113, Anti-TFPI Antibody, Efficiently Recovers Coagulation Efficacy through Blocking the Kunitz 2 Domain of Human TFPI

Senyon Choi, PhD, Sumin Lee, Heechun Kwak, Jaewoo Song, MD, Sungho Hwang, PhD

Blood (2016) 128 (22): 1406.

https://doi.org/10.1182/blood.V128.22.1406.1406

Published: 2016

Journal Articles

The Comparison of Hemostatic Effects of Recombinant Activated Factor VII (rFVIIa) in Thrombocytopenic Patients (pts) and Hemophilia Pts with Inhibitors

Gennadii M. Galstian, MD PhD, Irina V. Kolosova, MD, Eduard Gemdzhian, PhD, Vladimir Yu. Zorenko, MD PhD Prof., Tatyana A. Polyanskaya, MD PhD, Elena B. Orel, MD, Valeri G. Savchenko, MD PhD Prof.

Blood (2015) 126 (23): 4644.

https://doi.org/10.1182/blood.V126.23.4644.4644

Published: 2015

Journal Articles

Identification of Persons with Acquired Hemophilia in a Large Electronic Health Record Database

Michael Wang, MD, Anissa Cyhaniuk, MS, David L Cooper, MD MBA, Neeraj N Iyer, PhD

Blood (2015) 126 (23): 3271.

https://doi.org/10.1182/blood.V126.23.3271.3271

Published: 2015

Journal Articles

Structure-Activity Relationship of Pro- and Anticoagulant Effects of Fucus Vesiculosus Fucoidan

Michael Dockal, PhD, Susanne Till, PhD, Zhenqing Zhang, Sabine Knappe, PhD, Sabrina Reutterer, Catherine Quinn, Christoph Redl, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD, Christina Szabo

Blood (2012) 120 (21): 3353.

https://doi.org/10.1182/blood.V120.21.3353.3353

Published: 2012

Journal Articles

Severe Acute Hepatitis Following Administration of Rabbit Antithymocyte Globulin in Reduced Intensity Conditioning Regimen Before Allo-SCT. A Single Center Experience

Clàmence Màdiavilla, Stephane Vigouroux, MD, Reza Tabrizi, MD, Arnaud Pigneux, MD, PhD, Noel Milpied, MD

Blood (2012) 120 (21): 4135.

https://doi.org/10.1182/blood.V120.21.4135.4135

Published: 2012

Journal Articles

Structural and Functional Characterization of Fucoidan and Its Procoagulant Effect in An Ex Vivo Model of Factor VIII-Inhibited Guinea Pigs

Michael Dockal, PhD, Werner Hoellriegl, Zhenqing Zhang, Susanne Till, PhD, Sabine Knappe, PhD, Michael Palige, PhD, Alexandra Schiviz, Hartmut J. Ehrlich, MD, Christina Szabo, Eva-Maria Muchitsch, Friedrich Scheiflinger, PhD

Blood (2011) 118 (21): 2262.

https://doi.org/10.1182/blood.V118.21.2262.2262

Published: 2011

Journal Articles

Selection of a Suitable Rapid Turn Around and Sensitive Test for the Laboratory Monitoring of Newer Oral Anticoagulants, Rivaroxaban, Apixaban and Dabigatran,

Debra Hoppensteadt, Ph.D., Jeanine M. Walenga, PhD, Josephine Cunanan, MD, Omer Iqbal, MD, Bruce E Lewis, MD, Evi Kalodiki, PhD, Stephen Kahn, Jawed Fareed, PhD

Blood (2011) 118 (21): 3363.

https://doi.org/10.1182/blood.V118.21.3363.3363

Published: 2011

Journal Articles

Conservative Mutations in the Membrane-Binding Motif of Factor V C2 Domain to Residues of Pseudonaja Textilis Venom Factor V Confer Phosphatidylserine-Independent Activity

Valerie A Novakovic, M.S., Hongzhi Miao, Steven Pipe, MD, Gary E. Gilbert, M.D.

Blood (2011) 118 (21): 2243.

https://doi.org/10.1182/blood.V118.21.2243.2243

Published: 2011

Journal Articles

Evaluation of the Anti-Factor Xa Chromogenic Assay for Measuring Rivaroxaban Plasma Concentrations Using Calibrators and Controls

Meyer Michel Samama, Genevieve Contant, Theodore E Spiro, Elisabeth Perzborn, Céline Guinet, Yves Gourmelin, Léna Le Flem, Jean Luc Martinoli

Blood (2010) 116 (21): 3330.

https://doi.org/10.1182/blood.V116.21.3330.3330

Published: 2010

Journal Articles

Generic and Branded Versions of Argatroban Exhibit Differential Anticoagulant Effects In Whole Blood, Plasma Based Assays and Thrombin Generation Assays

Jawed Fareed, PhD, Debra Hoppensteadt, Ph.D., Omer Iqbal, MD, Jeanine M. Walenga, PhD, Bruce E Lewis, MD

Blood (2010) 116 (21): 5129.

https://doi.org/10.1182/blood.V116.21.5129.5129

Published: 2010

Journal Articles

Procoagulant Activity of Sulfated Polysaccharides

Michael Dockal, PhD, Sabine Knappe, PhD, Erwin Panholzer, Michael Palige, PhD, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD

Blood (2010) 116 (21): 4419.

https://doi.org/10.1182/blood.V116.21.4419.4419

Published: 2010

Journal Articles

Biological Activity of the First Epidermal Growth Factor-Like Domain of Rat Coagulation Factor VII

Heng Mei, Yu Hu, Huafang Wang, Xiaoping Zhang, Tao Guo, Shiang Huang, MD

Blood (2008) 112 (11): 4094.

https://doi.org/10.1182/blood.V112.11.4094.4094

Published: 2008

Journal Articles

Evaluating the Role of a New Dilute Prothrombin Time Assay ACTICLOT dPT in Lupus Anticoagulant Testing.

Jeffrey S. Dlott, MD, Maryellen Belter, MT(ASCP), Ellyn Ercolano, Clare Santulli, MT(ASCP), Enriqueta R. Guinto, Ph.D., Robert S. Greenfield, Ph.D.

Blood (2007) 110 (11): 3629.

https://doi.org/10.1182/blood.V110.11.3629.3629

Published: 2007

Journal Articles

Thromboplastin Composition Affects the Sensitivity of Prothrombin Time (PT) Clotting Tests To Direct Factor Xa Inhibitors.

Stephanie A. Smith, DVM, James H. Morrissey, PhD

Blood (2007) 110 (11): 928.

https://doi.org/10.1182/blood.V110.11.928.928

Published: 2007

Journal Articles

Factor Xa Inhibitors Can Be Differentiated in Xa, IIa and Microparticle Generation and Other Whole Blood Based Assays.

Omer Iqbal, MD, Cafer Adiguzel, MD., Debra Hoppensteadt, PH.D., Josephine Cunannan, MD., Jawed Fareed, PH.D.

Blood (2007) 110 (11): 931.

https://doi.org/10.1182/blood.V110.11.931.931

Published: 2007

Journal Articles

The Mutations SER2117→LEU, and TRP/TRP2063/64→MET/PHE in the Hydrophobic Spikes of the Factor V C2 Domain Lead to Tenacious Phospholipid Binding and Suggest a Mechanism through Which Phosphatidylserine Activates the Prothrombinase Complex.

Gary E. Gilbert, MD, Valerie A. Novakovic, M.S., Randal J. Kaufman, Ph.D., Hongzhi Miao, B.S., Steven W. Pipe, M.D.

Blood (2007) 110 (11): 2703.

https://doi.org/10.1182/blood.V110.11.2703.2703

Published: 2007

Journal Articles

Thrombophilic Patients with Migraines Have a High Incidence of Antiphospholipid Antibodies.

Zella Rose Zeigler, MD, Andrea L. Cortese Hassett, PhD

Blood (2005) 106 (11): 4133.

https://doi.org/10.1182/blood.V106.11.4133.4133

Published: 2005

Journal Articles

Demystifying Tissue Factor.

Saulius Butenas, Ph.D., Matthew T. Gissel, Beth A. Bouchard, Ph.D., Kathleen E. Brummel, Ph.D., Behnaz Parhami-Seren, Ph.D., Kenneth G. Mann, Ph.D.

Blood (2004) 104 (11): 1936.

https://doi.org/10.1182/blood.V104.11.1936.1936

Published: 2004

Journal Articles

Fluorogenic Assays for Functional Factor VIIa and Tissue Factor.

Sara J. Ethier, B.S., Saulius Butenas, Ph.D., Richard J. Jenny, Ph.D.

Blood (2004) 104 (11): 1740.

https://doi.org/10.1182/blood.V104.11.1740.1740

Published: 2004

NARROW

Factor Xa Inhibitory Profile of Apixaban, Betrixaban, Edoxaban and Rivaroxaban Does Not Fully Reflect Their Biologic Spectrum

MG1113, Anti-TFPI Antibody, Efficiently Recovers Coagulation Efficacy through Blocking the Kunitz 2 Domain of Human TFPI

The Comparison of Hemostatic Effects of Recombinant Activated Factor VII (rFVIIa) in Thrombocytopenic Patients (pts) and Hemophilia Pts with Inhibitors

Identification of Persons with Acquired Hemophilia in a Large Electronic Health Record Database

Structure-Activity Relationship of Pro- and Anticoagulant Effects of Fucus Vesiculosus Fucoidan

Severe Acute Hepatitis Following Administration of Rabbit Antithymocyte Globulin in Reduced Intensity Conditioning Regimen Before Allo-SCT. A Single Center Experience

Structural and Functional Characterization of Fucoidan and Its Procoagulant Effect in An Ex Vivo Model of Factor VIII-Inhibited Guinea Pigs

Selection of a Suitable Rapid Turn Around and Sensitive Test for the Laboratory Monitoring of Newer Oral Anticoagulants, Rivaroxaban, Apixaban and Dabigatran,

Conservative Mutations in the Membrane-Binding Motif of Factor V C2 Domain to Residues of Pseudonaja Textilis Venom Factor V Confer Phosphatidylserine-Independent Activity

Evaluation of the Anti-Factor Xa Chromogenic Assay for Measuring Rivaroxaban Plasma Concentrations Using Calibrators and Controls

Generic and Branded Versions of Argatroban Exhibit Differential Anticoagulant Effects In Whole Blood, Plasma Based Assays and Thrombin Generation Assays

Procoagulant Activity of Sulfated Polysaccharides

Biological Activity of the First Epidermal Growth Factor-Like Domain of Rat Coagulation Factor VII

Evaluating the Role of a New Dilute Prothrombin Time Assay ACTICLOT dPT in Lupus Anticoagulant Testing.

Thromboplastin Composition Affects the Sensitivity of Prothrombin Time (PT) Clotting Tests To Direct Factor Xa Inhibitors.

Factor Xa Inhibitors Can Be Differentiated in Xa, IIa and Microparticle Generation and Other Whole Blood Based Assays.

The Mutations SER2117→LEU, and TRP/TRP2063/64→MET/PHE in the Hydrophobic Spikes of the Factor V C2 Domain Lead to Tenacious Phospholipid Binding and Suggest a Mechanism through Which Phosphatidylserine Activates the Prothrombinase Complex.

Thrombophilic Patients with Migraines Have a High Incidence of Antiphospholipid Antibodies.

Demystifying Tissue Factor.

Fluorogenic Assays for Functional Factor VIIa and Tissue Factor.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only